Head-To-Head Analysis: Zenas Biopharma (ZBIO) vs. Its Competitors
Zenas Biopharma (NASDAQ:ZBIO – Get Free Report) is one of 422 public companies in the “Biotechnology” industry, but how does it compare to its rivals? We will compare Zenas Biopharma to similar businesses based on the strength of its earnings, dividends, profitability, valuation, analyst recommendations, risk and institutional ownership. Analyst Ratings This is a summary […]
More Stories
Oppenheimer & Co. Inc. Trims Stake in Invesco S&P 500 Equal Weight Industrials ETF (NYSEARCA:RSPN)
Oppenheimer & Co. Inc. lowered its stake in shares of Invesco S&P 500 Equal Weight Industrials ETF (NYSEARCA:RSPN – Free...
NVIDIA Corporation (NASDAQ:NVDA) Shares Sold by Stanley Laman Group Ltd.
Stanley Laman Group Ltd. lessened its stake in shares of NVIDIA Corporation (NASDAQ:NVDA – Free Report) by 34.7% in the...
Oppenheimer Asset Management Inc. Acquires 27,225 Shares of Sabre Corporation (NASDAQ:SABR)
Oppenheimer Asset Management Inc. grew its holdings in shares of Sabre Corporation (NASDAQ:SABR – Free Report) by 6.4% in the...
Sky Investment Group LLC Grows Stock Position in NVIDIA Corporation (NASDAQ:NVDA)
Sky Investment Group LLC increased its stake in NVIDIA Corporation (NASDAQ:NVDA – Free Report) by 0.7% in the first quarter,...
Smithbridge Asset Management Inc. DE Purchases New Position in NVIDIA Corporation (NASDAQ:NVDA)
Smithbridge Asset Management Inc. DE purchased a new stake in NVIDIA Corporation (NASDAQ:NVDA – Free Report) in the first quarter,...
Oppenheimer & Co. Inc. Increases Position in Paycom Software, Inc. (NYSE:PAYC)
Oppenheimer & Co. Inc. lifted its stake in shares of Paycom Software, Inc. (NYSE:PAYC – Free Report) by 149.5% during...